|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PAPSS1-GAB1 (FusionGDB2 ID:62244) |
Fusion Gene Summary for PAPSS1-GAB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PAPSS1-GAB1 | Fusion gene ID: 62244 | Hgene | Tgene | Gene symbol | PAPSS1 | GAB1 | Gene ID | 9061 | 128869 |
Gene name | 3'-phosphoadenosine 5'-phosphosulfate synthase 1 | phosphatidylinositol glycan anchor biosynthesis class U | |
Synonyms | ATPSK1|PAPSS|SK1 | CDC91L1|GAB1|GPIBD21 | |
Cytomap | 4q25 | 20q11.22 | |
Type of gene | protein-coding | protein-coding | |
Description | bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 13-prime-phosphoadenosine 5-prime-phosphosulfate synthase 1PAPS synthase 1PAPSS 1SK 1adenylyl-sulfate kinasesulfate adenylyltransferasesulfurylase kinase 1 | phosphatidylinositol glycan anchor biosynthesis class U proteinCDC91 (cell division cycle 91, S. cerevisiae, homolog)-like 1GPI transamidase component PIG-UGPI transamidase subunitcell division cycle 91-like 1 proteincell division cycle protein 91-li | |
Modification date | 20200313 | 20200322 | |
UniProtAcc | . | Q13480 | |
Ensembl transtripts involved in fusion gene | ENST00000265174, ENST00000511304, | ENST00000262995, ENST00000262994, ENST00000505913, ENST00000515388, | |
Fusion gene scores | * DoF score | 7 X 6 X 4=168 | 8 X 7 X 5=280 |
# samples | 7 | 9 | |
** MAII score | log2(7/168*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/280*10)=-1.63742992061529 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PAPSS1 [Title/Abstract] AND GAB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PAPSS1(108565957)-GAB1(144336629), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PAPSS1 | GO:0000103 | sulfate assimilation | 14747722 |
Hgene | PAPSS1 | GO:0050428 | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 14747722|23207770 |
Tgene | GAB1 | GO:0006506 | GPI anchor biosynthetic process | 15034568 |
Tgene | GAB1 | GO:0046425 | regulation of JAK-STAT cascade | 15034568 |
Fusion gene breakpoints across PAPSS1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across GAB1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ESCA | TCGA-L7-A56G | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
ChimerDB4 | ESCA | TCGA-L7-A56G | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
Top |
Fusion Gene ORF analysis for PAPSS1-GAB1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000265174 | ENST00000262995 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
In-frame | ENST00000265174 | ENST00000262994 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
5CDS-5UTR | ENST00000265174 | ENST00000505913 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
5CDS-intron | ENST00000265174 | ENST00000515388 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
intron-3CDS | ENST00000511304 | ENST00000262995 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
intron-3CDS | ENST00000511304 | ENST00000262994 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
intron-5UTR | ENST00000511304 | ENST00000505913 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
intron-intron | ENST00000511304 | ENST00000515388 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000265174 | PAPSS1 | chr4 | 108565957 | - | ENST00000262995 | GAB1 | chr4 | 144336629 | + | 9261 | 1779 | 210 | 3881 | 1223 |
ENST00000265174 | PAPSS1 | chr4 | 108565957 | - | ENST00000262994 | GAB1 | chr4 | 144336629 | + | 4053 | 1779 | 210 | 3791 | 1193 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000265174 | ENST00000262995 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + | 7.75E-05 | 0.9999224 |
ENST00000265174 | ENST00000262994 | PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + | 0.000788426 | 0.99921155 |
Top |
Fusion Genomic Features for PAPSS1-GAB1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + | 9.01E-06 | 0.99999094 |
PAPSS1 | chr4 | 108565957 | - | GAB1 | chr4 | 144336629 | + | 9.01E-06 | 0.99999094 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PAPSS1-GAB1 |
Go to FGviewer for the breakpoints of chr4:108565957-chr4:144336629 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | GAB1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Adapter protein that plays a role in intracellular signaling cascades triggered by activated receptor-type kinases. Plays a role in FGFR1 signaling. Probably involved in signaling by the epidermal growth factor receptor (EGFR) and the insulin receptor (INSR). Involved in the MET/HGF-signaling pathway (PubMed:29408807). {ECO:0000269|PubMed:29408807}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 419_422 | 502.0 | 625.0 | Nucleotide binding | ATP 2 |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 62_67 | 502.0 | 625.0 | Nucleotide binding | ATP 1 |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 106_109 | 502.0 | 625.0 | Region | Adenylyl sulfate binding |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 132_133 | 502.0 | 625.0 | Region | Adenylyl sulfate binding |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 184_185 | 502.0 | 625.0 | Region | Adenylyl sulfate binding |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 1_225 | 502.0 | 625.0 | Region | Adenylyl-sulfate kinase |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 89_92 | 502.0 | 625.0 | Region | Adenylyl sulfate binding |
Tgene | GAB1 | chr4:108565957 | chr4:144336629 | ENST00000262994 | 0 | 10 | 449_540 | 24.0 | 695.0 | Compositional bias | Note=Pro-rich | |
Tgene | GAB1 | chr4:108565957 | chr4:144336629 | ENST00000262995 | 0 | 11 | 449_540 | 24.0 | 725.0 | Compositional bias | Note=Pro-rich |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 521_525 | 502.0 | 625.0 | Nucleotide binding | ATP 2 |
Hgene | PAPSS1 | chr4:108565957 | chr4:144336629 | ENST00000265174 | - | 10 | 12 | 234_624 | 502.0 | 625.0 | Region | Sulfate adenylyltransferase |
Tgene | GAB1 | chr4:108565957 | chr4:144336629 | ENST00000262994 | 0 | 10 | 5_116 | 24.0 | 695.0 | Domain | PH | |
Tgene | GAB1 | chr4:108565957 | chr4:144336629 | ENST00000262995 | 0 | 11 | 5_116 | 24.0 | 725.0 | Domain | PH |
Top |
Fusion Gene Sequence for PAPSS1-GAB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000265174_ENST00000262995_TCGA-L7-A56G_PAPSS1_chr4_108565957_-_GAB1_chr4_144336629_length(transcript)=9261nt_BP=1779nt GCGAGCGCTGAAGCTCCGCCCCCAGCTTCTACCTCCGGTTCTATCCCGGCGTTTCGCCCTTCCCCACAGACCTCTGCCCCGGACCCATTT CCGAGGCGCGCCGCATGCGCCGCGCAACCCAGGCCACGAGCACGGGCGCGTGCTTAAGTCAGCGCGCGCCCGCTCCGACGCGAGGAGGCC CCGCCCTCCAGCCCCGCCCCGCTCGCTGGCCTGCCCTCCTCTTGCTACCCTCCCGGCGCAGAGAACCCCGGCTGCTCAGCGCGCTCCGCG GTCATGGAGATCCCCGGGAGCCTGTGCAAGAAAGTCAAACTGAGCAATAACGCGCAGAACTGGGGAATGCAGAGAGCAACCAATGTCACC TACCAAGCCCATCATGTCAGCAGGAACAAGAGAGGTCAGGTGGTGGGGACCAGAGGTGGCTTTCGTGGTTGCACAGTTTGGCTAACAGGC TTGTCTGGAGCGGGAAAGACTACTGTGAGCATGGCCTTGGAGGAGTACCTGGTTTGTCATGGTATTCCATGCTACACTCTGGATGGTGAC AATATTCGTCAAGGTCTCAATAAAAATCTTGGCTTTAGTCCTGAAGACAGAGAAGAGAATGTTCGACGCATCGCAGAAGTTGCTAAACTG TTTGCAGATGCTGGCTTAGTGTGCATCACAAGTTTCATATCACCTTACACTCAGGATCGCAACAATGCAAGGCAAATTCATGAAGGTGCA AGTTTACCGTTTTTTGAAGTATTTGTTGATGCTCCTCTGCATGTTTGTGAACAGAGGGATGTCAAAGGACTCTACAAAAAAGCCCGGGCA GGAGAAATTAAAGGTTTCACTGGGATCGATTCTGAATATGAAAAGCCAGAGGCCCCTGAGTTGGTGCTGAAAACAGACTCCTGTGATGTA AATGACTGTGTCCAGCAAGTTGTGGAACTTCTACAGGAACGGGATATTGTACCTGTGGATGCATCTTATGAAGTAAAAGAACTATATGTG CCAGAAAATAAACTTCATTTGGCAAAAACAGATGCGGAAACATTACCAGCACTGAAAATTAATAAAGTGGATATGCAGTGGGTGCAGGTT TTGGCAGAAGGTTGGGCAACCCCATTGAATGGCTTTATGAGAGAGAGGGAGTACTTGCAGTGCCTTCATTTTGATTGTCTTCTGGATGGA GGTGTCATTAACTTGTCAGTACCTATAGTTCTGACTGCGACTCATGAAGATAAAGAGAGGCTGGACGGCTGTACAGCATTTGCTCTGATG TATGAGGGCCGCCGTGTGGCCATTCTTCGCAATCCAGAGTTTTTTGAGCACAGGAAAGAGGAGCGCTGTGCCAGACAGTGGGGAACGACA TGCAAGAACCACCCCTATATTAAGATGGTGATGGAACAAGGAGATTGGCTGATTGGAGGAGATCTTCAAGTCTTGGATCGAGTTTATTGG AATGATGGTCTTGATCAGTATCGTCTTACTCCTACTGAGCTAAAGCAGAAATTTAAAGATATGAATGCTGATGCTGTCTTTGCATTTCAA CTACGCAACCCAGTGCACAATGGACATGCCCTGTTAATGCAGGATACCCATAAGCAACTTCTAGAGAGGGGCTACCGGCGCCCTGTCCTC CTCCTCCACCCTCTGGGTGGCTGGACAAAGGATGACGATGTTCCTTTGATGTGGCGTATGAAGCAGCATGCTGCAGTGTTGGAGGAAGGA GTTCTGAATCCTGAGACGACAGTGGTGGCCATCTTCCCATCTCCCATGATGTATGCTGGACCAACTGAGGCATGGAAGAGGAGATGGTTC GTGTTACGCAGTGGCCGTTTAACTGGAGATCCAGATGTTTTGGAATATTACAAAAATGATCATGCCAAGAAGCCTATTCGTATTATTGAT TTAAATTTATGTCAACAAGTAGATGCTGGATTGACATTTAACAAAAAAGAGTTTGAAAACAGCTACATTTTTGATATCAACACTATTGAC CGGATTTTCTACTTGGTAGCAGACAGCGAGGAGGAGATGAATAAGTGGGTTCGTTGTATTTGTGACATCTGTGGGTTTAATCCAACAGAA GAAGATCCTGTGAAGCCACCTGGCAGCTCTTTACAAGCACCAGCTGATTTACCTTTAGCTATAAATACAGCACCACCATCCACCCAGGCA GATTCATCCTCTGCTACTCTACCTCCTCCATATCAGCTAATCAATGTTCCACCACACCTGGAAACTCTTGGCATTCAGGAGGATCCTCAA GACTACCTGTTGCTCATCAACTGTCAAAGCAAGAAGCCCGAACCCACCAGAACGCATGCTGATTCTGCAAAATCCACCTCTTCTGAAACA GACTGCAATGATAACGTCCCTTCTCATAAAAATCCTGCTTCCTCCCAGAGCAAACATGGAATGAATGGCTTTTTTCAGCAGCAAATGATA TACGACTCTCCACCTTCACGTGCCCCATCTGCTTCAGTTGACTCCAGCCTTTATAACCTGCCCAGGAGTTATTCCCATGATGTTTTACCA AAGGTGTCTCCATCAAGTACTGAAGCAGATGGAGAACTCTATGTTTTTAATACCCCATCTGGGACATCGAGTGTAGAGACTCAAATGAGG CATGTATCTATTAGTTATGACATTCCTCCAACACCTGGTAATACTTATCAGATTCCACGAACATTTCCAGAAGGAACCTTGGGACAGACA TCAAAGCTAGACACTATTCCAGATATTCCTCCACCTCGGCCACCGAAACCACATCCAGCTCATGACCGATCTCCTGTGGAAACGTGTAGT ATCCCACGCACCGCCTCAGACACTGACAGTAGTTACTGTATCCCTACAGCAGGGATGTCGCCTTCACGTAGTAATACCATTTCCACTGTG GATTTAAACAAATTGCGAAAAGATGCTAGTTCTCAAGACTGCTATGATATTCCACGAGCATTTCCAAGTGATAGATCTAGTTCACTTGAA GGCTTCCATAACCACTTTAAAGTCAAAAATGTGTTGACAGTGGGAAGTGTTTCAAGTGAAGAACTGGATGAAAATTACGTCCCAATGAAT CCCAATTCACCACCACGACAACATTCCAGCAGTTTTACAGAACCAATTCAGGAAGCAAATTATGTGCCAATGACTCCAGGAACATTTGAT TTTTCCTCATTTGGAATGCAAGTTCCTCCTCCTGCTCATATGGGCTTCAGGTCCAGCCCAAAAACCCCTCCCAGAAGGCCAGTTCCTGTT GCAGACTGTGAACCACCCCCCGTGGATAGGAACCTCAAGCCAGACAGAAAAGGTCAAAGTCCTAAAATTTTAAGACTCAAACCCCATGGT TTAGAGCGAACTGATTCACAAACCATAGGTGACTTTGCTACAAGAAGAAAGGTCAAGCCAGCGCCTTTAGAAATAAAACCTTTGCCAGAA TGGGAAGAATTACAAGCCCCAGTTAGATCTCCCATCACTAGGAGTTTTGCTCGAGACTCTTCCAGGTTTCCCATGTCCCCCCGACCAGAT TCAGTGCATAGCACAACTTCAAGCAGTGACTCACACGACAGTGAAGAGAATTATGTTCCCATGAACCCAAACCTGTCCAGTGAAGACCCA AATCTCTTTGGCAGTAACAGTCTTGATGGAGGAAGCAGCCCTATGATCAAGCCCAAAGGAGACAAACAGGTGGAATACTTAGATCTCGAC TTAGATTCTGGGAAATCCACACCACCACGTAAGCAAAAGAGCAGTGGCTCAGGCAGCAGTGTAGCAGATGAGAGAGTGGATTATGTTGTT GTTGACCAACAGAAGACCTTGGCTCTAAAGAGTACCCGGGAAGCCTGGACAGATGGGAGACAGTCCACAGAATCAGAAACGCCAGCGAAG AGTGTGAAATGAAAATATTGCCTTGCCATTTCTGAACAAAAGAAAACTGAATTGTAAAGATAAATCCCTTTTGAAGAATGACTTGACACT TCCACTCTAGGTAGATCCTCAAATGAGTAGAGTTGAAGTCAAAGGACCTTTCTGACATAATCAAGCAATTTAGACTTAAGTGGTGCTTTG TGGTATCTGAACAATTCATAACATGTAAATAATGTGGGAAAATAGTATTGTTTAGCTCCCAGAGAAACATTTGTTCCACAGTTAACACAC TCGTAGTATTACTGTATTTATGCACTTTTTCATCTAAAACATTGTTCTGGGTTTTCCCAATGTACCTTACCATAATTCCTTTGGGAGTTC TTGTTTTTTGTCACACTACTTTATATAACAATACTAAGTCAACTAAGCTACTTTTAGATTTGGAAATTGCTGTTTACAGTCTAACAACAT TAAAATGAGAGGTAGATTCACAAGTTAGCTTTCTACCTGAAGCTTCAGGTGATAACCATTAGCTTATACTTGGACTCATCATTTGTTGCC TTCCAAAATGCTGAGGATAATGTATGTACTGGTGTCAGGACCTAGTTCTCTGGTTAATGTACATTTAGTTTTTAATGGTGGAACTTTGTT ATATTTTGTTAATTACAGTGTTTTTGGTTCATTGAGTGAAGATTCTGCCGGGTGGGATCTTGCACCTTTGAAAGACTGAATAATTACACT ACCAAGTAAGCCTGCAAATCATTGATGGCATGCAGTGATGATGTGCTCTTACACTTGTTAACATGTATTAAGTGTTATTTGCAAAAGGTA GATTATGTAACCAATCAGGTACGTACCAGGCAGTGATGTGCTAATACACTGATCAGGTTTAGACAATGAGCTTTGGTTGTGTTCTTGTTA GTCCTAATATTGGTTTTCAGTTTGGAATTAATAAAGCAGTTGACATTCACTGTTAGTTACAGCAACATACTGTGATTTTTAATTAGATAG TAATTCAGATTTATTACTCTATGAAATTCTGTCTTTTGACACCATAGTGCCCTTTCTATGATTTTTTTTACTTAATATTCTTCTTGGCCT TATATTTAATTCCCTATGCAATTAATATTTTATATCTGCATTTTTTTAAAAAAAATAGATGTTATATAAGTGATTCTCGTATGTAGCACC TGTTGCTTTTCCACTGAAAGAATTACGGATTTTGTACTGTGATTTATATTCACTGCCCCAATTCAAGAAATATTGGAGCCTTGCTACAAT GTGAAATGTTATAGTCATGGACTCCTTCCAACCAGATTTCTGAAAACACCAGAGGGATGGTATAATTCTGTCTCACCTATAACATGGTCC TGTGACATAGATATTAAGACCACAAGTTGTAGTGAGGCTACAATTATATTCGTCTGTCTTGGCTTTGCAACATAATTTAGAAAGCACGTA TAGTTGTTTTTTAACCAAGTTACATACAATCTCATGTACTGATTTGAGACTTATAACAATTTTTGGAGGGGGCATAGAGAAAGGAGTGCC CACAGTTGAGGCATGACCCCCTCCATTCAGACCTCTAACTGTTGCCTGAGTACACAGATGTGCCCTGATTTCTGGCCCATTGGCCATAGT ACTGTGCCTAATCAATGTAATAGGTTTATTTTCCCAATCCTCAAACTAAAAATGTTCATAACAAGATGAATTGTAGACTAGTAACATTTG ATGCTTTTAAATATTTGCTTCTTTTTAAACAAAAACTAAAACCCAGAAGTGAATTTTTAGGTGGATTTTTAAATAAAAAAGATTGATTGA GTTTGGTGTGCAAGCTGTTTTATAATGAAACAACAAAATGAAATCTAAAATCCTGAAATGTGCCTAAACTATCAAAACACACGATACAGC TAATGTGTAAAGATGCTAAATTCTGTTACTTGGAGGATGAATATATTTAAGATTTAAAACACAATAATAAATACATGATTAATTCAAAAA TAAAAATCTTTACAGCTGCCTATCAAGGGTCTAAAGCACTTAATGAATGTTTTTAGTCTAACTTATCATTAACTTTTTACAAGTCACCAT ATTTGAAGATCTGTAGCACTCTGATTTTCAGAAAATTTTTCATTCTGAATAATTTAAAAATGGTGATGTATTAGAAAGGCAGTTTGCTTT AGAAAACTAAATCACATTGAACATTGTATTAGAGAATTAAATTAAAAGTTTCTTACAGAGCAGTATTTTCCAAACATTTTTAGCACTAGA ATCTTTTTAGATGAAATTTTATGTATAACCCCAATACATAAAGCCTGAAAACTCAATTTTATCAATATAAATGTATTTTGGGTTCACATT TATGCTTATTCATTTTGGCTCATTACTAAGCATAATAAGATTCTGAGTTATTTCTGAATAACACAAATGTGGAGTTATACATAGTTGATG AAACCAGCAGCCAATTTATAGCTATGCCCTGTTTTATTTGTATACTATCAAGAAAATTTTGATTCACACAAATGTAAGCAAAAATAATAG GTTTTAAACATACATCTCAGGAAATTCTTTAATTAGAGATAGCTAAAGTTATTCAAGGTCTATACAAAAATAAGTTATCCTGGTAGTGGA AGTTAATACATAAGCAGTCTCCAGTGTGGTAAAGTAGGGTATGTAACACATCAGAATGTGCGTTTTTATTAGGTTTTAAAATATGCACGT ATAAAAACTAAATTTGAATCAAACCCTTTTAACTCACCTCCAAGAAGCTAGACTTTGGCCAGGAATGGGCTAAAAACCACTGGTTAACGA TGTGACAGTTATGATCTTGGAGATTGGAAATCTTTCTTCCACATTAGAGTTCTTTACCTTAATTCCTTATTCTGAAAAATTGTAAGATTT TATGAAGGTTTGAATACTGAAGCACAGTTCTGCTTTCAAAAATTAAAATTCAAACTTGAAAAAGCTGTTTAACCCATGGAAGATATCATT TAGTAAGATGTAAAAGATTTTTTAAATCTACACTTCAGTTTATACATCTTTATCATTATCAATACTATATAAGTTACTGTGAGCATTTTA GAGAATTCCATAAAGGTACTATGAGTGTGTCTGTATGTGTGTGTATATATAGCATTGTATTTAATCATAGACTAAATTTAATTTGATATA GAAATACTACTTTACTTGTACATTAAGGTCATAATTTCTGCTGGACTCTTTTATATTTAATTAATGGGGATTATAGTCTTCCTTCATAAA TGCATTTAAACCTGAAATTGAACACCAGTGTTTTTCTTTTTCTACTTATGGGAAGTTGTCTGCTTCCCCCTTTAGAGAAAACAGTATTTT TATATTTTGTTAAAATATTAACTACTTTATGCCTACACACTATGCTGTAGATACTGATCATAATTCTTGGGTGTTCACAAACACTCCTAG TGCCTCTTTTTTGGCCCGTTGAAAGTGTTGGTATTACTACTTTCACTACAGAGCCTTTGGCCCTCTAATAATGCTGAGGTGGGCTGATCC TTCCCATTTCTGTCTTCGGGTCATTCTGGTAGGTCTTCTCCTCCACTGTCAAGTAAGCAATCAGGTCCGTGACAGGGATTGGACATATGA ACAAATTAAGTGGATACACACAGTGAGAAAGATACATGCATTCTATGGTAACAACTACTGTCAATAACATCTGATGTTACATGCACATTT ATATATATATAATTTTAAAAACTGAACTATGAGAAGCCATGGTATAAATGAATATTGTGGACATCATGGACTTGATATGATAGAAATCAA TTGTCAGCTTGAGAAAGTTGTTTTTAATCTGTCTAAATAGTTCATGCATTACTACAGTTAAAAATAGTTTCATTTGTCTTCTATAGACTT AATTTTATTCCGGTTCAGTATAATCTCTGTTAACAGAGTTTCAGCAAACTGATTGGTCAAGGTATTAACATAGCTTCTACTTCCTTTACT TAAAAAGATGTGGTTTTATGTAAGTTCTTGATTACTGATGATCATCCCAAATTTTGACAACAAAATCATATGTATAAATTTATTTCTCCC CTCTTGTTCATCATCTTTTGTAAAGGTCCCATTGTAGATCTTTTCTGCTACCAAATAAAACTTTTCAAACAATTTGGTTTCAAGACCTTA AATAGACAAGTTGGATACTAAGATTGTGAACTGATAAGGACATATAAATTTATATTTCCAGCCCTTCCTTAGAGTCTTTATCTGCATCAA AAACCCAATTCTGCCATTAACTGTGCTTCCCAGTCCCACCTCTATATGTCACTCATTTTCTGCAACAAAGATCTCACTAAATCATGTTGA AACACAAGTCATGATCCTCTCTAAGTAAATAGAAAAAGCTCCCTGGAAAAACTCTGTTGCCACATGCACGTGCCCTGTTACTCCTCCAGC CAGCCAGTGCTGCCAGCATTTTATTGTGTAAAAGTCCAAATAAATAAGGGCCTGCATGCAACCTTTATCTTCAGAAACTAGGTTTTATAT GTAAAATGTGACTTGGGAAATGATTCTGTTTATTAACTGGCTGGGATTTTTCATTTCTATGAAAGTTTCAAACATCTCCAGTACTTTATA AAATCCCAACAATTGCTGTAAGTCAGCACTTTGGTCCACTCAGCCCACCCAGCCCACTTGCAACTCTGACTCTTCACTGAATCATATTTG GGAAGTTTGGGTAGGGTGAGGCTATCTTCTTCAAGATTATTTTCTCATATGTCTGTCTGTCACCTTGTAAACCATGAGACTCCTGGGTAT TTGCATGTAACTTCTTTGAGGAAGTTACCACCATCTCTGATATAGACACACTTTTTGAGTTGCAGTTTCTGTTAGAATTTTTTGGAGACT AACTTGCCAATTCTGTGAATGTTATTGAATATTTAAAAAGCTGGGTCTGTAATGGGAGGCATTTTATTAGCTGTTGTGATTGGGTAACAT GTCCCCTTAGATTTCCTGATTTAAAATTATACAAAATTACTATTTTTGATAAAATAAAGGAACACCTACAGAAAATTAAGTTTCTAAGAT GTTTCTATACTTCATTAGAAAAGATTTTATTACTATTACTTATGGTTATTGGTGATTAACACTTAATGCGTCTCCTCTGATTTTGTGTTC CATGAGGTGCTTGGAACATTTGGAGTGCTCTGTGCGAGGGACATACAGTGATATAGGAAATTTAAAAATTAAAATAATACCCAAAACCCA CTTTATCAGATATGGTATTGTGATGGTTAATATTATGTGTCAACTTGGTGAGGCTATGGCGCCCATGTGTTTGGTCAAACACTAGCCTAG >In-frame_ENST00000265174_ENST00000262995_TCGA-L7-A56G_PAPSS1_chr4_108565957_-_GAB1_chr4_144336629_length(amino acids)=1223AA_start in transcript=210_stop in transcript=3881 MPSSCYPPGAENPGCSARSAVMEIPGSLCKKVKLSNNAQNWGMQRATNVTYQAHHVSRNKRGQVVGTRGGFRGCTVWLTGLSGAGKTTVS MALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVD APLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIVPVDASYEVKELYVPENKLHLAKT DAETLPALKINKVDMQWVQVLAEGWATPLNGFMREREYLQCLHFDCLLDGGVINLSVPIVLTATHEDKERLDGCTAFALMYEGRRVAILR NPEFFEHRKEERCARQWGTTCKNHPYIKMVMEQGDWLIGGDLQVLDRVYWNDGLDQYRLTPTELKQKFKDMNADAVFAFQLRNPVHNGHA LLMQDTHKQLLERGYRRPVLLLHPLGGWTKDDDVPLMWRMKQHAAVLEEGVLNPETTVVAIFPSPMMYAGPTEAWKRRWFVLRSGRLTGD PDVLEYYKNDHAKKPIRIIDLNLCQQVDAGLTFNKKEFENSYIFDINTIDRIFYLVADSEEEMNKWVRCICDICGFNPTEEDPVKPPGSS LQAPADLPLAINTAPPSTQADSSSATLPPPYQLINVPPHLETLGIQEDPQDYLLLINCQSKKPEPTRTHADSAKSTSSETDCNDNVPSHK NPASSQSKHGMNGFFQQQMIYDSPPSRAPSASVDSSLYNLPRSYSHDVLPKVSPSSTEADGELYVFNTPSGTSSVETQMRHVSISYDIPP TPGNTYQIPRTFPEGTLGQTSKLDTIPDIPPPRPPKPHPAHDRSPVETCSIPRTASDTDSSYCIPTAGMSPSRSNTISTVDLNKLRKDAS SQDCYDIPRAFPSDRSSSLEGFHNHFKVKNVLTVGSVSSEELDENYVPMNPNSPPRQHSSSFTEPIQEANYVPMTPGTFDFSSFGMQVPP PAHMGFRSSPKTPPRRPVPVADCEPPPVDRNLKPDRKGQSPKILRLKPHGLERTDSQTIGDFATRRKVKPAPLEIKPLPEWEELQAPVRS PITRSFARDSSRFPMSPRPDSVHSTTSSSDSHDSEENYVPMNPNLSSEDPNLFGSNSLDGGSSPMIKPKGDKQVEYLDLDLDSGKSTPPR -------------------------------------------------------------- >In-frame_ENST00000265174_ENST00000262994_TCGA-L7-A56G_PAPSS1_chr4_108565957_-_GAB1_chr4_144336629_length(transcript)=4053nt_BP=1779nt GCGAGCGCTGAAGCTCCGCCCCCAGCTTCTACCTCCGGTTCTATCCCGGCGTTTCGCCCTTCCCCACAGACCTCTGCCCCGGACCCATTT CCGAGGCGCGCCGCATGCGCCGCGCAACCCAGGCCACGAGCACGGGCGCGTGCTTAAGTCAGCGCGCGCCCGCTCCGACGCGAGGAGGCC CCGCCCTCCAGCCCCGCCCCGCTCGCTGGCCTGCCCTCCTCTTGCTACCCTCCCGGCGCAGAGAACCCCGGCTGCTCAGCGCGCTCCGCG GTCATGGAGATCCCCGGGAGCCTGTGCAAGAAAGTCAAACTGAGCAATAACGCGCAGAACTGGGGAATGCAGAGAGCAACCAATGTCACC TACCAAGCCCATCATGTCAGCAGGAACAAGAGAGGTCAGGTGGTGGGGACCAGAGGTGGCTTTCGTGGTTGCACAGTTTGGCTAACAGGC TTGTCTGGAGCGGGAAAGACTACTGTGAGCATGGCCTTGGAGGAGTACCTGGTTTGTCATGGTATTCCATGCTACACTCTGGATGGTGAC AATATTCGTCAAGGTCTCAATAAAAATCTTGGCTTTAGTCCTGAAGACAGAGAAGAGAATGTTCGACGCATCGCAGAAGTTGCTAAACTG TTTGCAGATGCTGGCTTAGTGTGCATCACAAGTTTCATATCACCTTACACTCAGGATCGCAACAATGCAAGGCAAATTCATGAAGGTGCA AGTTTACCGTTTTTTGAAGTATTTGTTGATGCTCCTCTGCATGTTTGTGAACAGAGGGATGTCAAAGGACTCTACAAAAAAGCCCGGGCA GGAGAAATTAAAGGTTTCACTGGGATCGATTCTGAATATGAAAAGCCAGAGGCCCCTGAGTTGGTGCTGAAAACAGACTCCTGTGATGTA AATGACTGTGTCCAGCAAGTTGTGGAACTTCTACAGGAACGGGATATTGTACCTGTGGATGCATCTTATGAAGTAAAAGAACTATATGTG CCAGAAAATAAACTTCATTTGGCAAAAACAGATGCGGAAACATTACCAGCACTGAAAATTAATAAAGTGGATATGCAGTGGGTGCAGGTT TTGGCAGAAGGTTGGGCAACCCCATTGAATGGCTTTATGAGAGAGAGGGAGTACTTGCAGTGCCTTCATTTTGATTGTCTTCTGGATGGA GGTGTCATTAACTTGTCAGTACCTATAGTTCTGACTGCGACTCATGAAGATAAAGAGAGGCTGGACGGCTGTACAGCATTTGCTCTGATG TATGAGGGCCGCCGTGTGGCCATTCTTCGCAATCCAGAGTTTTTTGAGCACAGGAAAGAGGAGCGCTGTGCCAGACAGTGGGGAACGACA TGCAAGAACCACCCCTATATTAAGATGGTGATGGAACAAGGAGATTGGCTGATTGGAGGAGATCTTCAAGTCTTGGATCGAGTTTATTGG AATGATGGTCTTGATCAGTATCGTCTTACTCCTACTGAGCTAAAGCAGAAATTTAAAGATATGAATGCTGATGCTGTCTTTGCATTTCAA CTACGCAACCCAGTGCACAATGGACATGCCCTGTTAATGCAGGATACCCATAAGCAACTTCTAGAGAGGGGCTACCGGCGCCCTGTCCTC CTCCTCCACCCTCTGGGTGGCTGGACAAAGGATGACGATGTTCCTTTGATGTGGCGTATGAAGCAGCATGCTGCAGTGTTGGAGGAAGGA GTTCTGAATCCTGAGACGACAGTGGTGGCCATCTTCCCATCTCCCATGATGTATGCTGGACCAACTGAGGCATGGAAGAGGAGATGGTTC GTGTTACGCAGTGGCCGTTTAACTGGAGATCCAGATGTTTTGGAATATTACAAAAATGATCATGCCAAGAAGCCTATTCGTATTATTGAT TTAAATTTATGTCAACAAGTAGATGCTGGATTGACATTTAACAAAAAAGAGTTTGAAAACAGCTACATTTTTGATATCAACACTATTGAC CGGATTTTCTACTTGGTAGCAGACAGCGAGGAGGAGATGAATAAGTGGGTTCGTTGTATTTGTGACATCTGTGGGTTTAATCCAACAGAA GAAGATCCTGTGAAGCCACCTGGCAGCTCTTTACAAGCACCAGCTGATTTACCTTTAGCTATAAATACAGCACCACCATCCACCCAGGCA GATTCATCCTCTGCTACTCTACCTCCTCCATATCAGCTAATCAATGTTCCACCACACCTGGAAACTCTTGGCATTCAGGAGGATCCTCAA GACTACCTGTTGCTCATCAACTGTCAAAGCAAGAAGCCCGAACCCACCAGAACGCATGCTGATTCTGCAAAATCCACCTCTTCTGAAACA GACTGCAATGATAACGTCCCTTCTCATAAAAATCCTGCTTCCTCCCAGAGCAAACATGGAATGAATGGCTTTTTTCAGCAGCAAATGATA TACGACTCTCCACCTTCACGTGCCCCATCTGCTTCAGTTGACTCCAGCCTTTATAACCTGCCCAGGAGTTATTCCCATGATGTTTTACCA AAGGTGTCTCCATCAAGTACTGAAGCAGATGGAGAACTCTATGTTTTTAATACCCCATCTGGGACATCGAGTGTAGAGACTCAAATGAGG CATGTATCTATTAGTTATGACATTCCTCCAACACCTGGTAATACTTATCAGATTCCACGAACATTTCCAGAAGGAACCTTGGGACAGACA TCAAAGCTAGACACTATTCCAGATATTCCTCCACCTCGGCCACCGAAACCACATCCAGCTCATGACCGATCTCCTGTGGAAACGTGTAGT ATCCCACGCACCGCCTCAGACACTGACAGTAGTTACTGTATCCCTACAGCAGGGATGTCGCCTTCACGTAGTAATACCATTTCCACTGTG GATTTAAACAAATTGCGAAAAGATGCTAGTTCTCAAGACTGCTATGATATTCCACGAGCATTTCCAAGTGATAGATCTAGTTCACTTGAA GGCTTCCATAACCACTTTAAAGTCAAAAATGTGTTGACAGTGGGAAGTGTTTCAAGTGAAGAACTGGATGAAAATTACGTCCCAATGAAT CCCAATTCACCACCACGACAACATTCCAGCAGTTTTACAGAACCAATTCAGGAAGCAAATTATGTGCCAATGACTCCAGGAACATTTGAT TTTTCCTCATTTGGAATGCAAGTTCCTCCTCCTGCTCATATGGGCTTCAGGTCCAGCCCAAAAACCCCTCCCAGAAGGCCAGTTCCTGTT GCAGACTGTGAACCACCCCCCGTGGATAGGAACCTCAAGCCAGACAGAAAAGTCAAGCCAGCGCCTTTAGAAATAAAACCTTTGCCAGAA TGGGAAGAATTACAAGCCCCAGTTAGATCTCCCATCACTAGGAGTTTTGCTCGAGACTCTTCCAGGTTTCCCATGTCCCCCCGACCAGAT TCAGTGCATAGCACAACTTCAAGCAGTGACTCACACGACAGTGAAGAGAATTATGTTCCCATGAACCCAAACCTGTCCAGTGAAGACCCA AATCTCTTTGGCAGTAACAGTCTTGATGGAGGAAGCAGCCCTATGATCAAGCCCAAAGGAGACAAACAGGTGGAATACTTAGATCTCGAC TTAGATTCTGGGAAATCCACACCACCACGTAAGCAAAAGAGCAGTGGCTCAGGCAGCAGTGTAGCAGATGAGAGAGTGGATTATGTTGTT GTTGACCAACAGAAGACCTTGGCTCTAAAGAGTACCCGGGAAGCCTGGACAGATGGGAGACAGTCCACAGAATCAGAAACGCCAGCGAAG AGTGTGAAATGAAAATATTGCCTTGCCATTTCTGAACAAAAGAAAACTGAATTGTAAAGATAAATCCCTTTTGAAGAATGACTTGACACT TCCACTCTAGGTAGATCCTCAAATGAGTAGAGTTGAAGTCAAAGGACCTTTCTGACATAATCAAGCAATTTAGACTTAAGTGGTGCTTTG TGGTATCTGAACAATTCATAACATGTAAATAATGTGGGAAAATAGTATTGTTTAGCTCCCAGAGAAACATTTGTTCCACAGTTAACACAC >In-frame_ENST00000265174_ENST00000262994_TCGA-L7-A56G_PAPSS1_chr4_108565957_-_GAB1_chr4_144336629_length(amino acids)=1193AA_start in transcript=210_stop in transcript=3791 MPSSCYPPGAENPGCSARSAVMEIPGSLCKKVKLSNNAQNWGMQRATNVTYQAHHVSRNKRGQVVGTRGGFRGCTVWLTGLSGAGKTTVS MALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVD APLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIVPVDASYEVKELYVPENKLHLAKT DAETLPALKINKVDMQWVQVLAEGWATPLNGFMREREYLQCLHFDCLLDGGVINLSVPIVLTATHEDKERLDGCTAFALMYEGRRVAILR NPEFFEHRKEERCARQWGTTCKNHPYIKMVMEQGDWLIGGDLQVLDRVYWNDGLDQYRLTPTELKQKFKDMNADAVFAFQLRNPVHNGHA LLMQDTHKQLLERGYRRPVLLLHPLGGWTKDDDVPLMWRMKQHAAVLEEGVLNPETTVVAIFPSPMMYAGPTEAWKRRWFVLRSGRLTGD PDVLEYYKNDHAKKPIRIIDLNLCQQVDAGLTFNKKEFENSYIFDINTIDRIFYLVADSEEEMNKWVRCICDICGFNPTEEDPVKPPGSS LQAPADLPLAINTAPPSTQADSSSATLPPPYQLINVPPHLETLGIQEDPQDYLLLINCQSKKPEPTRTHADSAKSTSSETDCNDNVPSHK NPASSQSKHGMNGFFQQQMIYDSPPSRAPSASVDSSLYNLPRSYSHDVLPKVSPSSTEADGELYVFNTPSGTSSVETQMRHVSISYDIPP TPGNTYQIPRTFPEGTLGQTSKLDTIPDIPPPRPPKPHPAHDRSPVETCSIPRTASDTDSSYCIPTAGMSPSRSNTISTVDLNKLRKDAS SQDCYDIPRAFPSDRSSSLEGFHNHFKVKNVLTVGSVSSEELDENYVPMNPNSPPRQHSSSFTEPIQEANYVPMTPGTFDFSSFGMQVPP PAHMGFRSSPKTPPRRPVPVADCEPPPVDRNLKPDRKVKPAPLEIKPLPEWEELQAPVRSPITRSFARDSSRFPMSPRPDSVHSTTSSSD SHDSEENYVPMNPNLSSEDPNLFGSNSLDGGSSPMIKPKGDKQVEYLDLDLDSGKSTPPRKQKSSGSGSSVADERVDYVVVDQQKTLALK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PAPSS1-GAB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PAPSS1-GAB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PAPSS1-GAB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | GAB1 | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Tgene | GAB1 | C1136382 | Sclerocystic Ovaries | 1 | CTD_human |
Tgene | GAB1 | C1854275 | DEAFNESS, AUTOSOMAL RECESSIVE 26 | 1 | CTD_human;UNIPROT |